Back to News
Market Impact: 0.2
BMY Crosses Below Key Moving Average Level
Source: Nasdaq
Market Technicals & FlowsHealthcare & Biotech
Bristol Myers Squibb shares fell about 3.6% on Monday, trading as low as $58.33 and crossing below their 200-day moving average of $59.40. The article reports a technical price move without identifying a company-specific catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
BMY-0.30
More News
- Cramer is closely watching Nvidia's massive buyback. Here's what he wants to see
- Why is Bristol-Myers Squibb stock sliding today?
- Why did Mattel stock surge 5% today?
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- S&P 500 Closes In on Record High as Tech Rallies
- The case for Nvidia’s stock to march even higher after clinching its first record high in months
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: AI-Powered Report Editing, Investor Relations, and Enhanced Search
- Automating Financial Model Updates: A Source-Controlled Workflow